National Commercial Business Director

Company: AstraZeneca
Location: Gaithersburg, MD 20878

Apply

Job Description

At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. As the National Commercial Business Director (Field Based Role) you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives. The North American Commercial field organization is the ‘face’ of AstraZeneca to our many healthcare stakeholders. AstraZeneca’s GU field team is part of the broader AstraZeneca commercial field team who represent many of the most well recognized and respected oncology products in the industry and build strong relationships with healthcare professionals.

AstraZeneca’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm, with the aim of bringing six new cancer medicines to patients between 2013 and 2020. A broad pipeline of next-generation medicines is organized into four key franchises, Immuno-oncology, Lung, Women’s Healthcare and Hematology focused principally on four disease areas – lung, breast, ovarian and the hematological malignancies. Science compels us to push the boundaries of what is possible. We trust in the potential of ideas and will pursue them to transform the way cancer is treated. With a world-class pipeline and some of the best experts in the industry, we’re in a great position to develop even more innovative therapeutic approaches. We are looking for a National Commercial Business Director who shares the same passion that can deliver innovation, and advocate for our products in the GU disease settings. The National Commercial Business Director, GU is responsible for ensuring sales forecasts and operational budgets are met or exceeded within the GU oncology business.